MedTrace Logo

Investigating the Clinical Utility of the MDS

NCT03109327 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2020-11-19

No results posted yet for this study

Summary

The purpose of this study is to establish the clinical utility of the Melanoma Detection System (MDS).

Conditions

Interventions

DIAGNOSTIC_TEST

Melanoma Detection System -MDS

Imaging of lesion using the MDS test.

Sponsors & Collaborators

  • NHS Lanarkshire

    collaborator OTHER_GOV

  • NHS Tayside

    collaborator OTHER_GOV

  • NHS Greater Glasgow and Clyde

    collaborator OTHER

  • University Hospitals, Leicester

    collaborator OTHER

  • University of Dundee

    collaborator OTHER

  • Orlucent, Inc

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2020-10-30
Completion
2020-10-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03109327 on ClinicalTrials.gov